NCT06955754View on ClinicalTrials.gov

A Study in Healthy People to Test How 3 Different Formulations of BI 764198 Are Taken up in the Body and How This is Influenced by Food

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

June 26, 2025

Study Completion Date

July 14, 2025

Conditions
Healthy
Interventions
DRUG

BI 764198, formulation 1

BI 764198, formulation 1

DRUG

BI 764198, formulation 2

BI 764198, formulation 2

DRUG

BI 764198, formulation 3

BI 764198, formulation 3

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach/Riss

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY